Jason Newland, M.D., M.Ed.  jgnewland@wustl.edu

Associate Professor of Pediatrics, Infectious Diseases
Infectious Diseases

phone: (314) 454-6050

Education

  • BS, University of Notre Dame1996
  • MD, University of Oklahoma College of Medicine2000
  • M Ed, University of Cincinnati, Cincinnati Children's Hospital Medical Center2011

Training

  • Intern and Resident in Pediatrics, University of Nebraska Medical Center and Creighton Medical Center2000 - 2003
  • Fellow, Pediatric Infectious Diseases, Children's Hospital of Philadelphia2003 - 2006
  • Summer Program in Clinical Effectiveness, Harvard School of Public Health2010 - 2010
  • Advanced Improvement Methods, Cincinnati Children's Hospital2013 - 2013
  • Patient Safety Executive Development Program (IHI)2014 - 2014

Licensure and Board Certification

  • MO, Physician and Surgeon 2006
  • KS, Physician and Surgeon 2006
  • ABP Subspecialty, Pediatric Infectious Diseases 2007
  • American Board of Pediatrics 2015

Honors

  • Eagle Scout1990
  • Novartis Community Service Award1998
  • Podilarian Award for commitment, leadership, and advocacy on the part of patients and fellow students1999
  • William A. Delaney Jr. Award, outstanding senior student in pediatrics2000
  • IDSA Kass Award for outstanding research by a student or resident2002
  • Pediatric House Officer Teaching Award2002
  • George Measaki Award for outstanding resident research2003
  • Stephen A. Chartrand Award for community service2003
  • Teaching Fellow of the Year, Children's Hospital of Philadelphia2004
  • Daniel Scagliotti Award, Educator of the Year, Children's Mercy Hospital2008
  • Kansas City Business Journal Best Doctors List2011
  • Golden Apple Mercy Mentor, Children's Mercy Hospital2012
  • John and Marion Kreamer Research Excellence Award, Excellence in Pediatric Research2013
  • Member for the Society of Pediatric Research2013
  • Fellow of Pediatric Infectious Diseases Society2014
  • Kansas City Business Journal Best Doctors List2014
  • Patient Safety Executive Development Scholarship2014
  • Golden Apple Mercy Mentor, Children's Mercy Hospital2014 - 2015
  • Participant, White House Forum on Antibiotic Stewardship2015
  • Member of the American Pediatric Society2016

Recent Publications view all (91)


Publication Co-Authors

  1. Antibiotic Prophylaxis Is Associated with Subsequent Resistant Infections in Children with an Initial Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae Infection. Antimicrob Agents Chemother. 2017;61(5). PMID:28289030 
  2. Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS): A Quality Improvement Collaborative. J Pediatric Infect Dis Soc. 2017. PMID:28379408 
  3. Current State of Antimicrobial Stewardship in Children's Hospital Emergency Departments Infect Control Hosp Epidemiol. 2017;38(4):469-475. PMID:28173888 
  4. Experience With a Care Process Model in the Evaluation of Pediatric Musculoskeletal Infections in a Pediatric Emergency Department. Pediatr Emerg Care. 2017. PMID:28328692 
  5. Variability in Antifungal and Antiviral Use in Hospitalized Children. Infect Control Hosp Epidemiol. 2017;1-4. PMID:28294077 
  6. Extracorporeal Membrane Oxygenation-Associated Bloodstream Infections In Children. Pediatr Infect Dis J. 2017;36(3):346-347. PMID:27902647 
  7. Clinical Impact of an Antibiotic Stewardship Program at a Children's Hospital. Infect Dis Ther. 2017;6(1):103-113. PMCID:PMC5336414  PMID:27913975 
  8. Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application. Infect Dis Ther. 2016. PMID:28039666 
  9. Integrating a Rapid Diagnostic Test and Antimicrobial Stewardship: Optimizing Discharge Antibiotics in Skin and Soft Tissue Infections. Pediatr Infect Dis J. 2016. PMID:27649364 
  10. Best Practices for Treatment of Invasive Methicillin-Susceptible Staphylococcus aureus Infections: The Case for Oxacillin. J Pediatric Infect Dis Soc. 2016. PMID:27609072 
  11. Impact of an Educational Intervention to Improve Antibiotic Prescribing for Nurse Practitioners in a Pediatric Urgent Care Center J Pediatr Health Care. 2016. doi:10.1016/j.pedhc.2016.07.005  PMID:27567148 
  12. Failure to Thrive Hospitalizations and Risk Factors for Readmission to Children's Hospitals. Hosp Pediatr. 2016;6(8):468-75. PMID:27439432 
  13. Costs of Antimicrobial Stewardship Programs at US Children's Hospitals. Infect Control Hosp Epidemiol. 2016;37(7):852-4. PMID:27020133 
  14. Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients. Antimicrob Agents Chemother. 2016;60(7):4237-43. PMCID:PMC4914666  PMID:27139486 
  15. Extended- Versus Narrower-Spectrum Antibiotics for Appendicitis. Pediatrics. 2016;138(1). PMID:27354453 
  16. Risk Factors for and Outcomes of Catheter-Associated Peritonitis in Children: The SCOPE Collaborative. Clin J Am Soc Nephrol. 2016. PMID:27340282 
  17. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):e51-77. PMID:27080992 
  18. Executive Summary: Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 2016;62(10):1197-202. PMID:27118828 
  19. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. JAMA. 2016;315(17):1864-73. PMID:27139059 
  20. Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients: An Observational Cohort Study. Infect Dis Ther. 2016. doi:10.1007/s40121-016-0105-2  PMID:26972929 
  21. Reductions in neonatal listeriosis: "Collateral benefit" of Group B streptococcal prophylaxis? J Infect. 2016;72(3):317-23. doi:10.1016/j.jinf.2015.12.015  PMID:26772166 
  22. Outpatient Parenteral Antimicrobial Therapy in Pediatric Medicaid Enrollees. J Pediatric Infect Dis Soc. 2016. doi:10.1093/jpids/piv106  PMID:26803327 
  23. Pediatric Antimicrobial Discharge Stewardship: An Unmet Need. JAMA Pediatr. 2016;1-2. doi:10.1001/jamapediatrics.2015.3369  PMID:26752682 
  24. Encouraging Antibiotic Development and Endorsing Conservation: Tandem Approaches to Our Declining Antibiotic Reserves. Infect Control Hosp Epidemiol. 2016;1-2. doi:10.1017/ice.2015.329  PMID:26732605 
  25. Antimicrobial Stewardship Barriers and Goals in Pediatric Oncology and Bone Marrow Transplantation: A Survey of Antimicrobial Stewardship Practitioners. Infect Control Hosp Epidemiol. 2015;1-5. doi:10.1017/ice.2015.295  PMID:26639441 
  26. Linezolid-Resistant Staphylococcus aureus in Children With Cystic Fibrosis. J Pediatric Infect Dis Soc. 2015;4(4):e163-5. doi:10.1093/jpids/piv071  PMID:26501474 
  27. Boiling Over: The Antimicrobial Stewardship Stew May Finally Be Ready. J Pediatric Infect Dis Soc. 2015;4(4):394-6. doi:10.1093/jpids/piv063  PMID:26501469 
  28. Identifying Antimicrobial Stewardship Targets for Pediatric Surgical Patients. J Pediatric Infect Dis Soc. 2015;4(4):e100-8. doi:10.1093/jpids/piv022  PMID:26407258 
  29. Clinical variables and Staphylococcus aureus virulence factors associated with venous thromboembolism in children. Thromb Res. 2015. doi:10.1016/j.thromres.2015.11.029  PMID:26709039 
  30. Management of the 2014 Enterovirus 68 Outbreak at a Pediatric Tertiary Care Center. Clin Ther. 2015;37(11):2411-8. doi:10.1016/j.clinthera.2015.06.015  PMID:26602757 
  31. Surgical Site Infection Reduction by the Solutions for Patient Safety Hospital Engagement Network. Pediatrics. 2015;136(5):e1353-60. doi:10.1542/peds.2015-0580  PMID:26438709 
  32. Cost of antimicrobial therapy across US children's hospitals. Infect Control Hosp Epidemiol. 2015;36(10):1242-4. doi:10.1017/ice.2015.159  PMID:26166408 
  33. Clinical Impact of an Antimicrobial Stewardship Program on Pediatric Hospitalist Practice, a 5-Year Retrospective Analysis. Hosp Pediatr. 2015;5(10):520-7. doi:10.1542/hpeds.2014-0250  PMID:26427920 
  34. New Horizons for Pediatric Antibiotic Stewardship. Infect Dis Clin North Am. 2015;29(3):503-11. doi:10.1016/j.idc.2015.05.003  PMCID:PMC4589217  PMID:26154663 
  35. Antibiotic utilization based on primary treatment of pediatric empyema. J Surg Res. 2015;196(2):320-4. doi:10.1016/j.jss.2015.02.053  PMID:25824668 
  36. Database Research for Pediatric Infectious Diseases. J Pediatric Infect Dis Soc. 2015;4(2):143-50. doi:10.1093/jpids/piv007  PMID:26407414 
  37. Clinical diagnoses and antimicrobials predictive of pediatric antimicrobial stewardship recommendations: a program evaluation. Infect Control Hosp Epidemiol. 2015;36(6):673-80. doi:10.1017/ice.2015.45  PMCID:PMC4583769  PMID:25773192 
  38. Review of Twitter for infectious diseases clinicians: useful or a waste of time? Clin Infect Dis. 2015;60(10):1533-40. doi:10.1093/cid/civ071  PMID:25652087 
  39. Enterovirus d68. A focused review and clinical highlights from the 2014 U.S. Outbreak. Ann Am Thorac Soc. 2015;12(5):775-81. doi:10.1513/AnnalsATS.201412-592FR  PMID:25714788 
  40. Infection prevention and control practices in children's hospitals. Infect Control Hosp Epidemiol. 2015;36(5):597-600. doi:10.1017/ice.2015.23  PMID:25666492 
  41. An Enterovirus D68 Outbreak Highlights the Value of Pediatric Infectious Disease Specialists. J Pediatric Infect Dis Soc. 2015;4(1):87-8. doi:10.1093/jpids/piu117  PMID:26407368 
  42. Antimicrobial stewardship programs in freestanding children's hospitals. Pediatrics. 2015;135(1):33-9. doi:10.1542/peds.2014-2579  PMID:25489018 
  43. Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults. J Infect Dis. 2014;210(8):1270-4. doi:10.1093/infdis/jiu245  PMCID:PMC4271072  PMID:24795475 
  44. Design of the standardizing care to improve outcomes in pediatric end stage renal disease collaborative. Pediatr Nephrol. 2014;29(9):1477-84. doi:10.1007/s00467-014-2891-7  PMID:25055994 
  45. Prevalence and characteristics of antimicrobial stewardship programs at freestanding children's hospitals in the United States. Infect Control Hosp Epidemiol. 2014;35(3):265-71. doi:10.1086/675277  PMID:24521592 
  46. Impact of Infectious Diseases Society of America/Pediatric Infectious Diseases Society guidelines on treatment of community-acquired pneumonia in hospitalized children. Clin Infect Dis. 2014;58(6):834-8. doi:10.1093/cid/ciu013  PMID:24399088 
  47. Linezolid use in hospitalized children. Pediatr Infect Dis J. 2014;33(1):e14-8. doi:10.1097/INF.0000000000000011  PMID:24352192 
  48. Antibiotic Management of Animal Bites in Children During the Methicillin-Resistant Staphylococcus aureus Era. J Pediatric Infect Dis Soc. 2013;2(4):379-81. doi:10.1093/jpids/pis096  PMID:26619500 
  49. Diagnosis and acute management of patients with concussion at children's hospitals. Arch Dis Child. 2013;98(12):934-8. doi:10.1136/archdischild-2012-303588  PMID:23852997 
  50. Identifying targets for antimicrobial stewardship in children's hospitals. Infect Control Hosp Epidemiol. 2013;34(12):1252-8. doi:10.1086/673982  PMID:24225609 
  51. Pediatric antimicrobial susceptibility trends across the United States. Infect Control Hosp Epidemiol. 2013;34(12):1244-51. doi:10.1086/673974  PMID:24225608 
  52. Neonatal and pediatric antimicrobial stewardship programs in Europe-defining the research agenda. Pediatr Infect Dis J. 2013;32(12):e456-65. doi:10.1097/INF.0b013e31829f0460  PMID:23958812 
  53. Incidence, classification, and risk stratification for Candida central line-associated bloodstream infections in pediatric patients at a tertiary care children's hospital, 2000-2010. Infect Control Hosp Epidemiol. 2013;34(12):1266-71. doi:10.1086/673988  PMID:24225611 
  54. Antimicrobial stewardship in pediatrics: how every pediatrician can be a steward. JAMA Pediatr. 2013;167(9):859-66. doi:10.1001/jamapediatrics.2013.2241  PMID:23857121 
  55. The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J. 2013;32(6):e242-53. doi:10.1097/INF.0b013e318286c612  PMID:23838740 
  56. Microbiology and antimicrobial treatment of pediatric cervical lymphadenitis requiring surgical intervention. Int J Pediatr Otorhinolaryngol. 2013;77(5):817-20. doi:10.1016/j.ijporl.2013.02.018  PMID:23531371 
  57. Use of Administrative Data for the Identificationof Laboratory-Confirmed Influenza Infection: The Validity ofInfluenza-Specific ICD-9 Codes. J Pediatric Infect Dis Soc. 2013;2(1):63-6. doi:10.1093/jpids/pis052  PMID:26619444 
  58. The use of intravenous colistin among children in the United States: results from a multicenter, case series. Pediatr Infect Dis J. 2013;32(1):17-22. doi:10.1097/INF.0b013e3182703790  PMCID:PMC4427054  PMID:22935871 
  59. Variation in Antibiotic Use for Children Hospitalized With Inflammatory Bowel Disease Exacerbation: A Multicenter Validation Study. J Pediatric Infect Dis Soc. 2012;1(4):306-13. doi:10.1093/jpids/pis053  PMCID:PMC3656543  PMID:23687581 
  60. Influence of hospital guidelines on management of children hospitalized with pneumonia. Pediatrics. 2012;130(5):e823-30. doi:10.1542/peds.2012-1285  PMID:23090342 
  61. Impact of a Prospective-Audit-With-Feedback Antimicrobial Stewardship Program at a Children's Hospital. J Pediatric Infect Dis Soc. 2012;1(3):179-86. doi:10.1093/jpids/pis054  PMID:26619405 
  62. Clinicians' Attitudes Towards an Antimicrobial Stewardship Program at a Children's Hospital. J Pediatric Infect Dis Soc. 2012;1(3):190-7. doi:10.1093/jpids/pis045  PMID:26619407 
  63. Antimicrobial stewardship in pediatric care: strategies and future directions. Pharmacotherapy. 2012;32(8):735-43. doi:10.1002/j.1875-9114.2012.01155.x  PMID:23307521 
  64. Unmet medical need in infectious diseases. Clin Infect Dis. 2012;54(11):1677-8. doi:10.1093/cid/cis275  PMCID:PMC3404719  PMID:22474176 
  65. Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int. 2012;32 Suppl 2:S32-86. doi:10.3747/pdi.2011.00091  PMCID:PMC3524923  PMID:22851742 
  66. Impact of a guideline on management of children hospitalized with community-acquired pneumonia. Pediatrics. 2012;129(3):e597-604. doi:10.1542/peds.2011-1533  PMID:22351891 
  67. The role of intention-to-treat analyses in randomized trials. Infect Control Hosp Epidemiol. 2012;33(2):207-8; author reply 208-10. doi:10.1086/663963  PMID:22227995 
  68. Demographics and microbiology of otorrhea through patent tubes failing ototopical and/or oral antibiotic therapy. Otolaryngol Head Neck Surg. 2011;145(6):1025-9. doi:10.1177/0194599811419098  PMID:21846926 
  69. Staphylococcal infections in the era of MRSA. Pediatr Rev. 2011;32(12):522-32. doi:10.1542/pir.32-12-522  PMID:22135422 
  70. Rapid increase in use of antiviral therapy for hospitalized children with influenza during the 2009 H1N1 epidemic. Pediatr Infect Dis J. 2011;30(10):895-7. doi:10.1097/INF.0b013e3182214e28  PMID:21587093 
  71. Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America. Pediatr Infect Dis J. 2011;30(9):736-9. doi:10.1097/INF.0b013e3182191c58  PMID:21772230 
  72. Influenza coinfection and outcomes in children with complicated pneumonia. Arch Pediatr Adolesc Med. 2011;165(6):506-12. doi:10.1001/archpediatrics.2010.295  PMID:21300649 
  73. Comparative effectiveness of pleural drainage procedures for the treatment of complicated pneumonia in childhood. J Hosp Med. 2011;6(5):256-63. doi:10.1002/jhm.872  PMCID:PMC3112472  PMID:21374798 
  74. Improving surveillance for pediatric Clostridium difficile infection: derivation and validation of an accurate case-finding tool. Pediatr Infect Dis J. 2011;30(3):e38-40. doi:10.1097/INF.0b013e3182027c22  PMID:21079527 
  75. Pharmacologic considerations for oseltamivir disposition: focus on the neonate and young infant. Paediatr Drugs. 2011;13(1):19-31. doi:10.2165/11536950-000000000-00000  PMID:21162598 
  76. Variability in pediatric infectious disease consultants' recommendations for management of community-acquired pneumonia. PLoS One. 2011;6(5):e20325. doi:10.1371/journal.pone.0020325  PMCID:PMC3105054  PMID:21655259 
  77. Variability in antibiotic use at children's hospitals. Pediatrics. 2010;126(6):1067-73. doi:10.1542/peds.2010-1275  PMCID:PMC4677056  PMID:21078728 
  78. Antibiotics provide no additional short-term benefit to surgical management of paediatric skin abscesses. Evid Based Med. 2010;15(5):138-9. doi:10.1136/ebm1101  PMID:20643760 
  79. Purpose and design of antimicrobial stewardship programs in pediatrics. Pediatr Infect Dis J. 2010;29(9):862-3. doi:10.1097/INF.0b013e3181ef2507  PMID:20720473 
  80. A complete course of intravenous antibiotics vs a combination of intravenous and oral antibiotics for perforated appendicitis in children: a prospective, randomized trial. J Pediatr Surg. 2010;45(6):1198-202. doi:10.1016/j.jpedsurg.2010.02.090  PMID:20620320 
  81. Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008. Pediatrics. 2010;125(6):e1294-300. doi:10.1542/peds.2009-2867  PMID:20478934 
  82. Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol. 2009;30(12):1211-7. doi:10.1086/648088  PMID:19852666 
  83. Update on terbinafine with a focus on dermatophytoses. Clin Cosmet Investig Dermatol. 2009;2:49-63. PMCID:PMC3047923  PMID:21436968 
  84. Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics. Paediatr Drugs. 2008;10(6):367-78. PMID:18998747 
  85. Neurologic complications in children hospitalized with influenza: characteristics, incidence, and risk factors. J Pediatr. 2007;150(3):306-10. doi:10.1016/j.jpeds.2006.11.054  PMID:17307552 
  86. Diagnosis of viral encephalitides: zoonotic-associated viruses. Pediatr Infect Dis J. 2006;25(8):741-2. doi:10.1097/01.inf.0000227815.41511.3b  PMID:16874176 
  87. Diagnosis of viral encephalitides: nonzoonotic-associated viruses. Pediatr Infect Dis J. 2006;25(8):739-40. doi:10.1097/01.inf.0000227818.40808.92  PMID:16874175 
  88. The child with aseptic meningitis. Pediatr Case Rev. 2003;3(4):218-21. doi:10.1097/01.PCA.0000083250.03358.9F  PMID:14520085 
  89. Viral meningitis and encephalitis: traditional and emerging viral agents. Semin Pediatr Infect Dis. 2003;14(2):72-82. doi:10.1053/spid.2003.127223  PMID:12881794 
  90. Encephalitis associated with influenza B virus infection in 2 children and a review of the literature. Clin Infect Dis. 2003;36(7):e87-95. doi:10.1086/368184  PMID:12652406 
  91. Association of neutropenia in systemic lupus erythematosus (SLE) with anti-Ro and binding of an immunologically cross-reactive neutrophil membrane antigen. Clin Exp Immunol. 2000;120(1):209-17. PMCID:PMC1905619  PMID:10759785 
Last updated: 04/26/2017
Wash U School of Medicine
Children's Hospital St. Louis
Children's Discovery Institute
© 2017 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130